Teva Pharmaceuticals (Israel)
In research, Teva Pharmaceuticals (Israel) stands highest in Medicine (#11,723 of 17,978 worldwide) and Health Sciences (#14,788 of 20,462 worldwide), over all time.
- World rank, all time
- #20,230 of 42,892
- Rank in Israel
- #85 of 156
- Research works
- 266 ▼ 23% vs 2013–17
- Citations
- 5.8k 21.7 per fractional work
- Top-10% rate
- 16.3% record average 16.5%
- Open access
- 34% world 28%
What is Teva Pharmaceuticals (Israel) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #11,723 of 17,978 | 21.8% | 127 | |
| Health SciencesDomain | #14,788 of 20,462 | 21.5% | 137 |
Each strip is that field’s whole ranked pool, with the notch where Teva Pharmaceuticals (Israel) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 13.9×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 13.9×
- Immunology and Microbiology 4.3×
- Medicine 2.8×
- Neuroscience 2.5×
- Chemistry 1.8×
- Economics, Econometrics and Finance 1.6×
- Veterinary 1.5×
- Biochemistry, Genetics and Molecular Biology 1.3×
- Decision Sciences 1.1×
- Mathematics 0.7×
- Computer Science 0.5×
- Health Professions 0.5×
- Engineering 0.5×
- Environmental Science 0.4×
- Psychology 0.3×
- Materials Science 0.3×
- Agricultural and Biological Sciences 0.1×
- Physics and Astronomy 0.1×
- Social Sciences 0.0×
- Arts and Humanities 0.0×
Which keywords describe research at Teva Pharmaceuticals (Israel)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Neurological Disorders, Genetics, Headache Disorders, Migraine, Inflammation, Cognitive Impairment, Parkinson's Disease and Mitochondrial Dysfunction.
- Surgery
- Seizures
- Agile Software Development
- Stroke
- Rheumatoid Arthritis
- Drug Discovery
- Antiepileptic Drugs
- Health Utility Measures
- Antidepressant
- Neurobiology
- Drug Resistance
- Diagnostic Criteria
- Clinical Guidelines
- Treatment-Resistant Depression
- Metabolic Syndrome
- Treatment
- Mitochondrial Dysfunction
- Migraine
- Genetics
- Inflammation
- Neurological Disorders
- Epidemiology
- Headache Disorders
- Cognitive Impairment
- Parkinson's Disease
- Oxidative Stress
- Quality of Life
- Antipsychotic Drugs
- Depression
- Neurocognitive Deficits
- Epilepsy
- Synaptic Plasticity
- Cost-effectiveness Analysis
- Ketamine
- Classification
- Neurodegeneration
- Inflammatory Bowel Disease
- Teratogenicity
- Empirical Studies
- Status Epilepticus
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Neurological Disorders4▲ 16×9 topics
- Inflammation4▲ 3.6×16 topics
- Epidemiology3▲ 1.74×25 topics
- Genetics3▲ 8.6×9 topics
- Headache Disorders3▲ 227×1 topic
- Migraine3▲ 133×1 topic
- Cognitive Impairment2▲ 18×5 topics
- Mitochondrial Dysfunction2▲ 14×4 topics
- Parkinson's Disease2▲ 17×6 topics
- Treatment2▲ 3.3×6 topics
- Oxidative Stress2▲ 2.3×9 topics
- Metabolic Syndrome2▲ 4.4×3 topics
- Quality of Life2▲ 2.5×7 topics
- Treatment-Resistant Depression2▲ 57×2 topics
- Antipsychotic Drugs2▲ 87×1 topic
- Clinical Guidelines2▲ 11×2 topics
- Depression2▲ 3.8×5 topics
- Diagnostic Criteria2▲ 15×4 topics
- Neurocognitive Deficits2▲ 87×1 topic
- Drug Resistance2▲ 11×4 topics
- Epilepsy2▲ 29×2 topics
- Neurobiology2▲ 12×4 topics
- Synaptic Plasticity1▲ 14×2 topics
- Antidepressant1▲ 109×1 topic
- Cost-effectiveness Analysis1▲ 32×1 topic
- Health Utility Measures1▲ 32×1 topic
- Ketamine1▲ 109×1 topic
- Antiepileptic Drugs1▲ 33×2 topics
- Classification1▲ 5.6×3 topics
- Drug Discovery1▲ 11×4 topics
- Neurodegeneration1▲ 8.2×4 topics
- Rheumatoid Arthritis1▲ 25×2 topics
- Inflammatory Bowel Disease1▲ 20×2 topics
- Stroke1▲ 13×4 topics
- Teratogenicity1▲ 44×2 topics
- Agile Software Development1▲ 88×1 topic
- Empirical Studies1▲ 88×1 topic
- Seizures1▲ 35×1 topic
- Status Epilepticus1▲ 45×1 topic
- Surgery1▲ 6.1×2 topics
Which research topics does Teva Pharmaceuticals (Israel) publish most on?
By volume in 2022–2025: Migraine and Headache Studies, Schizophrenia research and treatment, Treatment of Major Depression and Health Systems, Economic Evaluations, Quality of Life.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Migraine and Headache Studies Psychiatry and Mental health 3 works
- 2 Schizophrenia research and treatment Psychiatry and Mental health 2 works
- 3 Treatment of Major Depression Pharmacology 1 works
- 4 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 5 Artificial Intelligence in Healthcare and Education Health Informatics 1 works
- 6 Epilepsy research and treatment Psychiatry and Mental health 1 works
- 7 Software Engineering Techniques and Practices Information Systems 1 works
- 8 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 1 works
- 9 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 1 works
- 10 Pregnancy and Medication Impact Public Health, Environmental and Occupational Health 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Teva Pharmaceuticals (Israel)'s research output changed?
Output in 2018–2022 was 23% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Petah Tikva
- Rabin Medical Center
- Schneider Children's Medical Center
- New Technology (Israel)
- Geha Mental Health Center
- Gemalto (Israel)
- Beit Rivka Geriatric Medical Center
- Gilat Satellite Networks (Israel)
- Can-Fite BioPharma (Israel)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.